Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Månsson W[au]:

Search results

Items: 1 to 50 of 139

1.

In vitro prediction of in vivo absorption of ibuprofen from suspensions through rational choice of dissolution conditions.

Hofmann M, García MA, Al-Gousous J, Ruiz-Picazo A, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P.

Eur J Pharm Biopharm. 2020 Apr;149:229-237. doi: 10.1016/j.ejpb.2020.02.009. Epub 2020 Feb 26.

PMID:
32112894
2.

A novel technique for intraduodenal administration of drug suspensions/solutions with concurrent pH monitoring applied to ibuprofen formulations.

Hofmann M, Thieringer F, Nguyen MA, Månsson W, Galle PR, Langguth P.

Eur J Pharm Biopharm. 2019 Mar;136:192-202. doi: 10.1016/j.ejpb.2019.01.010. Epub 2019 Jan 16.

PMID:
30659894
3.

Long-term third-party assessment of results after continent cutaneous diversion with Lundiana pouch.

Liedberg F, Gudjonsson S, Xu A, Bendahl PO, Davidsson T, Månsson W.

BJU Int. 2017 Oct;120(4):530-536. doi: 10.1111/bju.13863. Epub 2017 Apr 19.

4.

A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma.

Patschan O, Sjödahl G, Chebil G, Lövgren K, Lauss M, Gudjonsson S, Kollberg P, Eriksson P, Aine M, Månsson W, Fernö M, Liedberg F, Höglund M.

Eur Urol. 2015 Nov;68(5):824-32; discussion 835-6. doi: 10.1016/j.eururo.2015.02.021. Epub 2015 Mar 11.

PMID:
25770486
5.

Urinary diversion: how experts divert.

Hautmann RE, Abol-Enein H, Lee CT, Mansson W, Mills RD, Penson DF, Skinner EC, Studer UE, Thueroff JW, Volkmer BG.

Urology. 2015 Jan;85(1):233-8. doi: 10.1016/j.urology.2014.06.075. Epub 2014 Nov 8. Review.

PMID:
25440985
6.

Urostomy and health-related quality of life in patients with lower urinary tract dysfunction.

Schultz A, Boye B, Jonsson O, Thind P, Månsson W.

Scand J Urol. 2015 Feb;49(1):2-7. doi: 10.3109/21681805.2013.876095. Epub 2014 Nov 5.

PMID:
25370732
7.

Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.

Sjödahl G, Lövgren K, Lauss M, Chebil G, Patschan O, Gudjonsson S, Månsson W, Fernö M, Leandersson K, Lindgren D, Liedberg F, Höglund M.

Urol Oncol. 2014 Aug;32(6):791-7. doi: 10.1016/j.urolonc.2014.02.007. Epub 2014 Apr 29.

8.

Rediversion after urinary diversion: a single-centre experience.

Liedberg F, Colleen S, Davidsson T, Månsson W.

Scand J Urol. 2014 Feb;48(1):99-104. doi: 10.3109/21681805.2013.817485. Epub 2013 Jul 29.

PMID:
23889158
9.

Functional results after orthotopic bladder substitution: a prospective multicentre study comparing four types of neobladder.

Paananen I, Ohtonen P, Perttilä I, Jonsson O, Edlund C, Wiklund P, Ljungberg B, Möller-Jensen K, Jonsson E, Månsson W.

Scand J Urol. 2014 Feb;48(1):90-8. doi: 10.3109/21681805.2013.799225. Epub 2013 Jul 17.

PMID:
23863091
10.

Toward a molecular pathologic classification of urothelial carcinoma.

Sjödahl G, Lövgren K, Lauss M, Patschan O, Gudjonsson S, Chebil G, Aine M, Eriksson P, Månsson W, Lindgren D, Fernö M, Liedberg F, Höglund M.

Am J Pathol. 2013 Sep;183(3):681-91. doi: 10.1016/j.ajpath.2013.05.013. Epub 2013 Jul 1.

11.

Impact of hospital volume on local recurrence and distant metastasis in bladder cancer patients treated with radical cystectomy in Sweden.

Sabir EF, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Wijkström H, Jahnson S.

Scand J Urol. 2013 Dec;47(6):483-90. doi: 10.3109/21681805.2013.787118. Epub 2013 Apr 16.

PMID:
23590830
12.

ICUD-EAU International Consultation on Bladder Cancer 2012: Urinary diversion.

Hautmann RE, Abol-Enein H, Davidsson T, Gudjonsson S, Hautmann SH, Holm HV, Lee CT, Liedberg F, Madersbacher S, Manoharan M, Mansson W, Mills RD, Penson DF, Skinner EC, Stein R, Studer UE, Thueroff JW, Turner WH, Volkmer BG, Xu A; International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012.

Eur Urol. 2013 Jan;63(1):67-80. doi: 10.1016/j.eururo.2012.08.050. Epub 2012 Aug 31. Review.

PMID:
22995974
13.

Preoperative staging of locally advanced bladder cancer before radical cystectomy using 3 tesla magnetic resonance imaging with a standardized protocol.

Liedberg F, Bendahl PO, Davidsson T, Gudjonsson S, Holmer M, Månsson W, Wallengren NO.

Scand J Urol. 2013 Apr;47(2):108-12. doi: 10.3109/00365599.2012.721394. Epub 2012 Sep 19.

PMID:
22989110
14.

DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation status.

Lauss M, Aine M, Sjödahl G, Veerla S, Patschan O, Gudjonsson S, Chebil G, Lövgren K, Fernö M, Månsson W, Liedberg F, Ringnér M, Lindgren D, Höglund M.

Epigenetics. 2012 Aug;7(8):858-67. doi: 10.4161/epi.20837. Epub 2012 Jun 18.

15.

The importance of being grade 3: WHO 1999 versus WHO 2004 pathologic grading.

Liedberg F, Lauss M, Patschan O, Aine M, Chebil G, Cwikiel M, Engilbertsson H, Gudjonsson S, Kollberg P, Sjödahl G, Månsson W, Lindgren D, Höglund M; Lund Bladder Cancer Group.

Eur Urol. 2012 Oct;62(4):620-3. Epub 2012 Jun 5. No abstract available.

PMID:
22698575
16.

Integrated genomic and gene expression profiling identifies two major genomic circuits in urothelial carcinoma.

Lindgren D, Sjödahl G, Lauss M, Staaf J, Chebil G, Lövgren K, Gudjonsson S, Liedberg F, Patschan O, Månsson W, Fernö M, Höglund M.

PLoS One. 2012;7(6):e38863. doi: 10.1371/journal.pone.0038863. Epub 2012 Jun 7.

17.

A molecular taxonomy for urothelial carcinoma.

Sjödahl G, Lauss M, Lövgren K, Chebil G, Gudjonsson S, Veerla S, Patschan O, Aine M, Fernö M, Ringnér M, Månsson W, Liedberg F, Lindgren D, Höglund M.

Clin Cancer Res. 2012 Jun 15;18(12):3377-86. doi: 10.1158/1078-0432.CCR-12-0077-T. Epub 2012 May 2.

18.

[Patients' acceptance of urinary diversion. The pouch of Sisyphus].

von Rundstedt FC, Roth S, Woodhouse CR, Månsson W, Gerharz EW.

Urologe A. 2012 Apr;51(4):515-21. doi: 10.1007/s00120-012-2817-6. German.

PMID:
22419011
19.

The value of bladder mapping and prostatic urethra biopsies for detection of carcinoma in situ (CIS).

Gudjónsson S, Bläckberg M, Chebil G, Jahnson S, Olsson H, Bendahl PO, Månsson W, Liedberg F.

BJU Int. 2012 Jul;110(2 Pt 2):E41-5. doi: 10.1111/j.1464-410X.2011.10654.x. Epub 2011 Oct 28.

20.

Long-term follow-up after radical cystectomy with emphasis on complications and reoperations: a Swedish population-based survey.

Liedberg F, Holmberg E, Holmäng S, Ljungberg B, Malmström PU, Månsson W, Nunez L, Wessman C, Wijkström H, Jahnson S.

Scand J Urol Nephrol. 2012 Feb;46(1):14-8. doi: 10.3109/00365599.2011.609835. Epub 2011 Aug 19.

PMID:
21854101
21.

A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1.

Sjödahl G, Lauss M, Gudjonsson S, Liedberg F, Halldén C, Chebil G, Månsson W, Höglund M, Lindgren D.

PLoS One. 2011 Apr 14;6(4):e18583. doi: 10.1371/journal.pone.0018583.

22.

Can tissue microarray-based analysis of protein expression predict recurrence of stage Ta bladder cancer?

Gudjónsson S, Bendahl PO, Chebil G, Höglund M, Lindgren D, Lundberg LM, Lövgren K, Fernö M, Månsson W, Liedberg F.

Scand J Urol Nephrol. 2011 Sep;45(4):270-7. doi: 10.3109/00365599.2011.568956. Epub 2011 Apr 20.

PMID:
21504385
23.

Pelvic exenteration for advanced and recurrent malignancy.

Zoucas E, Frederiksen S, Lydrup ML, Månsson W, Gustafson P, Alberius P.

World J Surg. 2010 Sep;34(9):2177-84. doi: 10.1007/s00268-010-0637-7.

PMID:
20512493
24.

Combined gene expression and genomic profiling define two intrinsic molecular subtypes of urothelial carcinoma and gene signatures for molecular grading and outcome.

Lindgren D, Frigyesi A, Gudjonsson S, Sjödahl G, Hallden C, Chebil G, Veerla S, Ryden T, Månsson W, Liedberg F, Höglund M.

Cancer Res. 2010 May 1;70(9):3463-72. doi: 10.1158/0008-5472.CAN-09-4213. Epub 2010 Apr 20.

25.

Prevention and management of complications following radical cystectomy for bladder cancer.

Lawrentschuk N, Colombo R, Hakenberg OW, Lerner SP, Månsson W, Sagalowsky A, Wirth MP.

Eur Urol. 2010 Jun;57(6):983-1001. doi: 10.1016/j.eururo.2010.02.024. Epub 2010 Feb 26. Review.

PMID:
20227172
26.

Urinary diversion after cystectomy for bladder cancer: a population-based study in Sweden.

Jahnson S, Damm O, Hellsten S, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Rosell J, Wijkstöm H.

Scand J Urol Nephrol. 2010 Mar;44(2):69-75. doi: 10.3109/00365590903449357.

PMID:
20001606
27.

Re: Richard J. Sylvester, Willem Oosterlinck. An immediate instillation after transurethral resection of bladder tumor in non-muscle-invasive bladder cancer: has the evidence changed? Eur Urol 2009;56;43-5.

Gudjónsson S, Månsson W, Holmäng S, Liedberg F.

Eur Urol. 2010 Mar;57(3):e28-9; author reply e30. doi: 10.1016/j.eururo.2009.11.026. Epub 2009 Nov 17. No abstract available.

PMID:
19931978
28.

A population-based study of patterns of care for muscle-invasive bladder cancer in Sweden.

Jahnson S, Damm O, Hellsten S, Holmäng S, Liedberg F, Ljungberg B, Malmström PU, Månsson W, Strömberg F, Wijkstöm H.

Scand J Urol Nephrol. 2009;43(4):271-6. doi: 10.1080/00365590902909778.

PMID:
19424934
29.

Should all patients with non-muscle-invasive bladder cancer receive early intravesical chemotherapy after transurethral resection? The results of a prospective randomised multicentre study.

Gudjónsson S, Adell L, Merdasa F, Olsson R, Larsson B, Davidsson T, Richthoff J, Hagberg G, Grabe M, Bendahl PO, Månsson W, Liedberg F.

Eur Urol. 2009 Apr;55(4):773-80. doi: 10.1016/j.eururo.2009.01.006. Epub 2009 Jan 13.

PMID:
19153001
30.

Extended lymph node dissection in patients with urothelial cell carcinoma of the bladder: can it make a difference?

Holmer M, Bendahl PO, Davidsson T, Gudjonsson S, Månsson W, Liedberg F.

World J Urol. 2009 Aug;27(4):521-6. doi: 10.1007/s00345-008-0366-9. Epub 2009 Jan 15.

PMID:
19145436
31.

MiRNA expression in urothelial carcinomas: important roles of miR-10a, miR-222, miR-125b, miR-7 and miR-452 for tumor stage and metastasis, and frequent homozygous losses of miR-31.

Veerla S, Lindgren D, Kvist A, Frigyesi A, Staaf J, Persson H, Liedberg F, Chebil G, Gudjonsson S, Borg A, Månsson W, Rovira C, Höglund M.

Int J Cancer. 2009 May 1;124(9):2236-42. doi: 10.1002/ijc.24183.

32.

Chairmen's summary.

Andersson L, Droller MJ, Adolfsson J, Månsson W, Kirkali Z, Boffetta P, Montironi R, Malmstrom PU, Tribukait B, Grossman HB.

Scand J Urol Nephrol Suppl. 2008 Sep;(218):7-11. doi: 10.1080/03008880802399684. No abstract available.

PMID:
18815912
33.

Incontinent urinary diversion.

Gudjónsson S, Davidsson T, Månsson W.

BJU Int. 2008 Nov;102(9 Pt B):1320-5. doi: 10.1111/j.1464-410X.2008.07977.x. No abstract available.

PMID:
19035899
34.

Recurrent and multiple bladder tumors show conserved expression profiles.

Lindgren D, Gudjonsson S, Jee KJ, Liedberg F, Aits S, Andersson A, Chebil G, Borg A, Knuutila S, Fioretos T, Månsson W, Höglund M.

BMC Cancer. 2008 Jun 30;8:183. doi: 10.1186/1471-2407-8-183.

35.

Tiling resolution array CGH and high density expression profiling of urothelial carcinomas delineate genomic amplicons and candidate target genes specific for advanced tumors.

Heidenblad M, Lindgren D, Jonson T, Liedberg F, Veerla S, Chebil G, Gudjonsson S, Borg A, Månsson W, Höglund M.

BMC Med Genomics. 2008 Jan 31;1:3. doi: 10.1186/1755-8794-1-3.

36.

Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?

Liedberg F, Anderson H, Chebil G, Gudjonsson S, Höglund M, Lindgren D, Lundberg LM, Lövgren K, Fernö M, Månsson W.

Urol Oncol. 2008 Jan-Feb;26(1):17-24. doi: 10.1016/j.urolonc.2006.08.021. Epub 2007 Oct 22.

PMID:
18190825
37.

Patient-assessed outcomes in Swedish and Egyptian men undergoing radical cystectomy and orthotopic bladder substitution--a prospective comparative study.

Månsson A, Al Amin M, Malmström PU, Wijkström H, Abol Enein H, Månsson W.

Urology. 2007 Dec;70(6):1086-90.

PMID:
18158023
38.

The value of the UroVysion assay for surveillance of non-muscle-invasive bladder cancer.

Gudjónsson S, Isfoss BL, Hansson K, Domanski AM, Warenholt J, Soller W, Lundberg LM, Liedberg F, Grabe M, Månsson W.

Eur Urol. 2008 Aug;54(2):402-8. Epub 2007 Dec 7.

PMID:
18082934
39.

Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.

Liedberg F, Anderson H, Bläckberg M, Chebil G, Davidsson T, Gudjonsson S, Jahnson S, Olsson H, Månsson W.

Scand J Urol Nephrol. 2007;41(4):290-6.

PMID:
17763219
40.

The rationale behind recommendations for follow-up after urinary diversion: an evidence-based approach.

Bakke A, Jensen KM, Jonsson O, Jónsson E, Månsson W, Paananen I, Schultz A, Thind P, Tuhkanen K.

Scand J Urol Nephrol. 2007;41(4):261-9. Review. No abstract available.

PMID:
17763215
41.

Bladder cancers respond to intravesical instillation of HAMLET (human alpha-lactalbumin made lethal to tumor cells).

Mossberg AK, Wullt B, Gustafsson L, Månsson W, Ljunggren E, Svanborg C.

Int J Cancer. 2007 Sep 15;121(6):1352-9.

42.

Distinct mitotic segregation errors mediate chromosomal instability in aggressive urothelial cancers.

Jin Y, Stewénius Y, Lindgren D, Frigyesi A, Calcagnile O, Jonson T, Edqvist A, Larsson N, Lundberg LM, Chebil G, Liedberg F, Gudjonsson S, Månsson W, Höglund M, Gisselsson D.

Clin Cancer Res. 2007 Mar 15;13(6):1703-12.

43.

Urothelial carcinoma in the prostatic urethra and prostate: current controversies.

Liedberg F, Chebil G, Månsson W.

Expert Rev Anticancer Ther. 2007 Mar;7(3):383-90. Review.

PMID:
17338657
44.

A convenient method for local drug administration at predefined sites in the entire gastrointestinal tract: experiences from 13 phase I studies.

Nyberg L, Månsson W, Abrahamsson B, Seidegård J, Borgå O.

Eur J Pharm Sci. 2007 Apr;30(5):432-40. Epub 2007 Feb 2.

PMID:
17336045
45.

Urinary diversion.

World Health Organization (WHO) Consensus Conference on Bladder Cancer, Hautmann RE, Abol-Enein H, Hafez K, Haro I, Mansson W, Mills RD, Montie JD, Sagalowsky AI, Stein JP, Stenzl A, Studer UE, Volkmer BG.

Urology. 2007 Jan;69(1 Suppl):17-49. Review.

PMID:
17280907
46.

Molecular characterization of early-stage bladder carcinomas by expression profiles, FGFR3 mutation status, and loss of 9q.

Lindgren D, Liedberg F, Andersson A, Chebil G, Gudjonsson S, Borg A, Månsson W, Fioretos T, Höglund M.

Oncogene. 2006 Apr 27;25(18):2685-96.

PMID:
16532037
47.

Mucosal host responses to bacteriuria in colonic and ileal neobladders.

Wullt B, Bergsten G, Carstensen J, Gustafsson E, Gebratsedik N, Holst E, Månsson W.

Eur Urol. 2006 Nov;50(5):1065-71; discussion 1071-2. Epub 2006 Feb 24.

PMID:
16530320
48.

Working capacity and well-being after radical cystectomy with continent cutaneous diversion.

Ohrström M, Davidsson T, Månsson W, Wohlfart B, Ekelund M.

Eur Urol. 2006 Apr;49(4):691-7. Epub 2006 Jan 17.

PMID:
16442699
49.

Cystometric and in vitro muscle studies of cystoplastic appendiceal segments in the rat.

Semerdzhiev Y, Frederiksen H, Hedlund P, Davidsson T, Mansson W, Uvelius B.

Neurourol Urodyn. 2006;25(3):259-267. doi: 10.1002/nau.20155.

PMID:
16408259
50.

Intraoperative sentinel node detection improves nodal staging in invasive bladder cancer.

Liedberg F, Chebil G, Davidsson T, Gudjonsson S, Månsson W.

J Urol. 2006 Jan;175(1):84-8; discussion 88-9.

PMID:
16406877

Supplemental Content

Loading ...
Support Center